Neural network could help clinicians look for 'ugly duckling' pre-cancerous skin lesions

February 17, 2021

A neural network system that analyzes photographs can rank and distinguish suspicious, potentially precancerous skin lesions, which can turn into the deadly skin malignancy melanoma if not caught and removed early. The system accurately scoped out suspicious lesions from 68 patients in a manner that mostly matched tried-and-true evaluations from dermatologists. The results suggest the platform could help clinicians spot suspicious lesions during clinical visits faster and on a larger scale, potentially allowing for earlier diagnosis and treatment. Melanoma is the deadliest form of skin cancer, but outcomes can be very good for patients who have their melanomas removed during the disease's earliest stages, when the lesion is still thin and has not spread deep into the skin. To screen for melanomas, clinicians typically evaluate large skin surfaces with the ABCDE set of criteria, searching for "ugly duckling" lesions that show signs of being pre-cancerous. Authorities have also started to roll out large skin cancer screening programs to reduce the burden of melanoma, but clinics lack scalable tools that can assess lesions in large numbers of patients. Here, Luis Soenksen and colleagues designed a neural network platform that takes photographs of skin lesions - even those taken with a cell phone camera - and rapidly identifies suspicious markings that may need follow-up testing. The team trained their technology with 38,283 photographs, including skin photos from 133 patients, and observed the method distinguished suspicious lesions from nonsuspicious ones with a sensitivity and specificity of 90.3% and 89.9%, respectively. In a separate experiment, the strategy also ranked "ugly duckling" lesions on the skin of 68 patients, yielding rankings that mostly matched assessments from 3 dermatologists. The authors add that future improvements may help address some current limitations with the system, such as by making it work with a wider range of cameras, light settings, and photographers.

American Association for the Advancement of Science

Related Melanoma Articles from Brightsurf:

Boosting treatments for metastatic melanoma
University of Cincinnati clinician-scientist Soma Sengupta, MD, PhD, says that new findings from her and Daniel Pomeranz Krummel's, PhD, team might have identified a treatment-boosting drug to enhance effectiveness of therapies for metastatic cancer and make them less toxic, giving patients a fighting chance at survival and improved quality of life.

A promising new tool in the fight against melanoma
An Edith Cowan University (ECU) study has revealed that a key blood marker of cancer could be used to select the most effective treatment for melanoma.

New targets for melanoma treatment
A collaborative study led by Monash University's Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute (ONJCRI) has uncovered new markers (HLA-associated peptides) that are uniquely present on melanoma tumours and could pave the way for therapeutic vaccines to be developed in the fight against melanoma.

Innovative smartphone-camera adaptation images melanoma and non-melanoma
An article published in the Journal of Biomedical Optics (JBO), ''Point-of-care, multispectral, smartphone-based dermascopes for dermal lesion screening and erythema monitoring,'' shows that standard smartphone technology can be adapted to image skin lesions, providing a low-cost, accessible medical diagnostic tool for skin cancer.

Antihistamines may help patients with malignant melanoma
Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma?

Blood test for deadly eye melanoma
A simple blood test could soon become the latest monitoring tool for the early detection of melanoma in the eye.

Analysis of melanoma in US by age groups
This study used registry data to determine annual rates of melanoma in pediatric, adolescent, young adult and adult age groups, and the findings suggest an apparent decrease among adolescent and young adults between 2006 and 2015 but increases in older adults.

Vitamin D dials down the aggression in melanoma cells
Vitamin D influences the behaviour of melanoma cells in the lab by making them less aggressive, Cancer Research UK scientists have found.

B cells linked to immunotherapy for melanoma
Immunotherapy uses our body's own immune system to fight cancer.

Five things to know about melanoma
'Five things to know about ... melanoma' in CMAJ (Canadian Medical Association Journal) provides a brief overview of this malignant skin cancer for physicians and patients.

Read More: Melanoma News and Melanoma Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to